Análisis Argos
SHC
SHCCara
Sotera Health Company · Healthcare
US$ 17.93
precio al 2026-07-04
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
46/100
LA RESPUESTA
El mercado le pide crezca 47.5% al año — más de lo que ha demostrado (7.1%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
✓Las ganancias crecieron 76% el último año.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
!Balance frágil: la deuda pesa sobre el negocio.
VALOR1/6FUTURO3/6PASADO3/6SALUD1/6DIVIDENDO1/6
El Iris de calidad
VALOR1/6FUTURO3/6PASADO3/6SALUD1/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance frágil
DividendoEl dividendo aún duerme
Score Argos46de 100Cara
Ingresos▲5%
US$ 1.2 B
Margen operativo▲25%
33.8%
Flujo de caja libre▲200%
US$ 0.2 B
Deuda neta
US$ 1.9 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 5.1B
P/E65.6x
EV/EBITDA13.2x
FCF yield2.9%
ROIC8.2%
Margen operativo33.8%
Crecim. ingresos+5.7%/año
Piotroski F6/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

seekingalpha.com · 8 jun
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com · 3 jun
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
seekingalpha.com · 19 may
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
globenewswire.com · 11 may
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.
fool.com · 6 may
Why Broyhill May Be Buying More Sotera Health Shares
Sotera Health offers sterilization and lab testing for healthcare and life sciences clients, supporting global regulatory compliance.
seekingalpha.com · 5 may
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
zacks.com · 5 may
Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com · 5 may
Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.14 per share a year ago.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.